Published in BMJ on March 04, 1995
Protein arginine deiminase 4: evidence for a reverse protonation mechanism. Biochemistry (2007) 1.45
Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors. ACS Chem Biol (2011) 1.25
Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors. Bioorg Med Chem (2007) 1.11
Coping with arthritis is experienced as a dynamic balancing process. A qualitative study. Clin Rheumatol (2011) 0.94
Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2. Ann Rheum Dis (2012) 0.92
Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening. BMC Bioinformatics (2012) 0.79
Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report. J Immunol Res (2015) 0.77
Association of the Smad3 and NFATc2 gene polymorphisms and their serum levels with susceptibility to rheumatoid arthritis in Polish cohorts. Clin Exp Immunol (2015) 0.75
Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. Br Med J (1977) 3.97
Sulphasalazine in rheumatoid arthritis. Br Med J (1980) 3.53
Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate. Ann Rheum Dis (1985) 2.35
Infertility may sometimes be associated with NSAID consumption. Br J Rheumatol (1996) 2.32
Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis. Ann Rheum Dis (1979) 2.30
Salazopyrin in rheumatoid arthritis. Agents Actions (1978) 2.15
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J (Clin Res Ed) (1986) 1.55
Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash. Ann Rheum Dis (1986) 1.33
Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment. Br Med J (1978) 1.30
Peripheral ulcerative keratitis 'corneal melt' and rheumatoid arthritis: a case series. Rheumatology (Oxford) (1999) 1.09
Rheumatoid arthritis: effects of a new agent (ICI 55 897) on serum acute phase proteins and the erythrocyte sedimentation rate. Ann Rheum Dis (1980) 1.07
Mönckeberg's arteriosclerosis and metabolic bone disease. Lancet (1980) 0.98
Neurofibromatosis masquerading as monoarticular juvenile arthritis. Br J Rheumatol (1997) 0.96
Clindamycin in bone and joint infections. J Antimicrob Chemother (1977) 0.92
Juvenile dermatomyositis associated with hereditary angioneurotic oedema. Arch Dis Child (2002) 0.89
Long-term follow-up of juvenile-onset cutaneous polyarteritis nodosa associated with streptococcal infection. Br J Rheumatol (1997) 0.88
Sulphasalazine for rheumatoid arthritis: relationship between dose, acetylator phenotype and response to treatment. Br J Rheumatol (1986) 0.87
ABC of rheumatology. Rheumatoid arthritis--II: Treatment. BMJ (1995) 0.80
Deposition of gold in ocular structures, although known, is rare. A case of ocular chrysiasis in a patient of rheumatoid arthritis on gold treatment is presented. Eye (Lond) (2004) 0.78
TNF +489 polymorphism does not contribute to susceptibility to rheumatoid arthritis. Clin Exp Rheumatol (2003) 0.76
Histiocytic medullary reticulosis with hypogammaglobulinaemia and disseminated intravascular coagulation. Postgrad Med J (1977) 0.75
Sulphasalazine therapy in RA. Ann Rheum Dis (1986) 0.75
Management of rheumatoid arthritis. Br Med J (1977) 0.75
Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis. Br Med J (Clin Res Ed) (1987) 0.75
Salazopyrin in rheumatoid arthritis. 1978. Agents Actions (1994) 0.75
Sulphasalazine in the long term management of rheumatoid arthritis. Drugs (1986) 0.75
Sulphasalazine for rheumatoid arthritis. Studies on dose, acetylator phenotype and efficacy. Drugs (1986) 0.75
Methotrexate and sulphasalazine as combination therapy in rheumatoid arthritis. Br J Rheumatol (1994) 0.75
Sulphasalazine treatment in rheumatoid arthritis. J Rheumatol (1986) 0.75
[Experiences in long-term therapy of rheumatoid arthritis with sulfasalazine tablets]. Z Rheumatol (1987) 0.75
Non-invasive assessment of drug action in rheumatoid arthritis and related disorders. Pharmacol Ther (1981) 0.75
Sulphasalazine in rheumatoid arthritis. Lancet (1985) 0.75